Targeting Nox4 and Interleukin-6 crosstalk can be a potential strategy for Gastric Cancer prevention

Over 950000 million people are being affected in Gastric Cancer (GC) in each year. And so many patients are dying for its lethality. That means prognosis and treatment strategies are not well enough for its treatment. So, in the present scenario research work on this disease is truly significant and necessary. Nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase or NOX) is a family of enzyme consists of seven NOX isoforms members, such as- NOX1, NOX2, NOX3, NOX4, NOX5 and dual oxidase (DUOX) 1 and 2, that possess similarities in terms of enzyme function and structure. All these seven isoforms are transmembrane proteins (having six transmembrane domains) with a NADPH binding site, a FAD-binding site and four heme-binding histidines. Among these enzymes (NOX family), NOX4 is highly expressed in Gastric Cancer (GC) cells. As well as it was observed that high expression of NOX4 is correlated with worse overall survival (OS) in all GC patients. Interestingly, high mRNA expression of NOX4 indicates a worse OS in stage III/IV GC patients, but not in stage I/II GC patients. That is suggesting, NOX4 may contribute to the GC progression and play a crucial role in its (GC) late-stage. And it is observed that NOX4 is related with the cell invasion by regulating the JAK2/STAT3 signaling pathway. Functionally this enzyme family is leading with production of Reactive Oxygen Species (ROS) by utilizing NADPH. Few common examples of ROS are hydrogen peroxide (H2O2), superoxide anion (O2-) and hydroxyl radicles (OH) etc. These NOX producing ROS are connected to carcinogenesis as it is involved with so many cellular processes like cell proliferation, DNA damage and angiogenesis etc. On the other hand, recent studies show that Interleukin-6 (IL-6) is significantly related with the cell invasion and JAK2/STAT3 activation. That means both compounds (NOX4 and IL-6) are related with JAK2/STAT3 signaling pathway. And this JAK2/STAT3 signaling actually activates those genes which are associated with cell proliferation and anti-apoptosis. So, it is suggested that, targeting both Nox4 and IL-6 may be a fruitful strategy in GC treatmen

Immune evasion by cancer stem cells ensures tumor initiation and failure of immunotherapy

Cancer stem cells (CSCs) are a small subpopulation of cells that drive the formation and progression of tumors. However, during tumor initiation, how CSCs communicate with neighbouring immune cells to overcome the powerful immune surveillance barrier in order to form, spread, and maintain the tumor, remains poorly understood. It is, therefore, absolutely necessary to understand how a small number of tumor-initiating cells (TICs) survive immune attack during (a) the “elimination phase” of “tumor immune-editing”, (b) the establishment of regional or distant tumor after metastasis, and (c) recurrence after therapy. Mounting evidence suggests that CSCs suppress the immune system through a variety of distinct mechanisms that ensure the survival of not only CSCs but also non-stem cancer cells (NSCCs), which eventually form the tumor mass. In this review article, the mechanisms via which CSCs change the immune landscape of the tissue of origin, which contains macrophages, dendritic cells (DCs), myeloid-derived suppressor cells (MDSCs), natural killer (NK) cells, and tumor-infiltrating lymphocytes, in favour of tumorigenesis were discussed. The failure of cancer immunotherapy might also be explained by such interaction between CSCs and immune cells. This review will shed light on the critical role of CSCs in tumor immune evasion and emphasize the importance of CSC-targeted immunotherapy as a cutting-edge technique for battling cancer by restricting communication between immune cells and CSCs

Association of Angiogenic and Inflammatory Markers with Power Doppler Ultrasound Vascularity Grade and DAS28-CRP in Early Rheumatoid Arthritis: A Comparative Analysis

Objective. Upregulation of various proinflammatory and angiogenic mediators orchestrates the typical pathological synovial alterations in rheumatoid arthritis (RA). DAS28-CRP is commonly used for assessment of RA disease activity and power Doppler ultrasonography (PDUS) is an important modality for assessing synovial vascularity. This study was intended to look for the association of various inflammatory and angiogenic mediators, with respect to different PDUS vascularity grades and disease activity status, in early RA patients. Methods. 50 early RA patients (<6 months disease duration) with either moderate or high disease activity and 30 healthy controls were included in this study. RA patients were subcategorized based on PDUS vascularity grading of wrist joints. Serum levels of proinflammatory cytokines [tumor necrosis factor-α (TNF- α); interleukin-6(IL-6)] and angiogenic markers [angiopoietin-1 and 2 (Ang-1 and Ang-2); vascular endothelial growth factor (VEGF) ] were measured and compared among different patient subgroups. Results. Among 50 patients, 22 and 28 patients had moderate and high DAS28-CRP score, respectively. Patients with grade 3 PDUS score, even with moderate DAS value, showed a significant rise in Ang-1 (p<0.02), VEGF (p<0.008), Ang-2 (p <0.001), and TNF-α (p<0.005) level compared to grade 2 PDUS patients with high DAS values. Conclusion. Higher serum level of angiogenic and inflammatory markers was noted among patients with moderate disease activity but with advanced PDUS vascularity (grade 3) in comparison to high disease activity group with less severe PDUS vascularity (grade 2). PDUS vascularity grading better reflects some markers of angiogenesis and inflammation, than composite disease activity index